The origin of chromosome imbalances in neuroblastoma

Cancer Genetics and Cytogenetics

Volumn 176, Issue 1, 2007, Pages 28-34

  Stallings, Raymond L ^a   Yoon, Kihoon ^b   Kwek, Stephen ^b   Ko, Daijin ^c  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b One UTSA Circle   (United States)

^c UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICROSATELLITE DNA;

ANALYTIC METHOD; ARTICLE; CHROMOSOME ABERRATION; CHROMOSOME REARRANGEMENT; CONTROLLED STUDY; DNA SEQUENCE; DNA STRAND BREAKAGE; GC RICH SEQUENCE; GENOMICS; HUMAN; HUMAN CELL; NEUROBLASTOMA; PRIORITY JOURNAL; SOMATIC CELL;

CHROMOSOME BREAKAGE; CHROMOSOME MAPPING; CPG ISLANDS; EXONS; HUMANS; NEUROBLASTOMA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REPETITIVE SEQUENCES, NUCLEIC ACID;

EID: 34250155987     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2007.02.014     Document Type: Article

References (25)

1. Brodeur G.M., Seeger R.C., Schwab M., Varmus H.E., and Bishop J.M. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 224 (1984) 1121-1124
2. Attiyeh E.F., London W.B., Mosse Y.P., Wang Q., Winter C., Khazi D., McGrady P.W., Seeger R.C., Look A.T., Shimada H., Brodeur G.M., Cohn S.L., Matthay K.K., and Maris J.M. Chromosome 1p and 11q deletions and outcome in neuroblastoma. N Engl J Med 353 (2005) 2243-2253
3. Spitz R., Hero B., Ernestus K., and Berthold F. Deletions in chromosome arms 3p and 11q are new prognostic markers in localized and 4s neuroblastoma. Clin Cancer Res 9 (2003) 52-58
4. Brinkschmidt C., Christiansen H., Terpe H.J., Simon R., Lampert F., Boecker W., and Dockhorn-Dworniczak B. Distal chromosome 17 gains in neuroblastomas detected by comparative genomic hybridization (CGH) are associated with a poor clinical outcome. Med Pediatr Oncol 36 (2001) 11-13
5. Lastowska M., Van Roy N., Bown N., Speleman F., Roberts P., Lunec J., Strachan T., Pearson A.D., and Jackson M.S. Molecular cytogenetic definition of 17q translocation breakpoints in neuroblastoma. Med Pediatr Oncol 36 (2001) 20-23
6. Vandesompele J., Baudis M., De Preter K., Van Roy N., Ambros P., Bown N., Brinkschmidt C., Christiansen H., Combaret V., Lastowska M., Nicholson J., O'Meara A., Plantaz D., Stallings R., Brichard B., Van den Broecke C., De Bie S., De Paepe A., Laureys G., and Speleman F. Unequivocal delineation of clinicogenetic subgroups and development of a new model for improved outcome prediction in neuroblastoma. J Clin Oncol 23 (2005) 2280-2299
7. Guo C., White P.S., Weiss M.J., Hogarty M.D., Thompson P.M., Stram D.O., Gerbing R., Matthay K.K., Seeger R.C., Brodeur G.M., and Maris J.M. Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas. Oncogene 18 (1999) 4948-4957
8. Novo F.J., and Vizmanos J.L. Chromosome translocations in cancer: computational evidence for the random generation of double-strand breaks. Trends Genet 22 (2006) 193-196
9. Breen C.J., O'Meara A., McDermott M., Mullarkey M., and Stallings R.L. Coordinate deletion of chromosome 3p and 11q in neuroblastoma detected by comparative genomic hybridization. Cancer Genet Cytogenet 120 (2000) 44-49
10. Vandesompele J., Van Roy N., Van Gele M., Laureys G., Ambros P., Heimann P., Devalck C., Schuuring E., Brock P., Otten J., Gyselinck J., De Paepe A., and Speleman F. Genetic heterogeneity of neuroblastoma studied by comparative genomic hybridization. Genes Chromosomes Cancer 23 (1998) 141-152
11. Van Roy N., Laureys G., Van Gele M., Opdenakker G., Miura R., van der Drift P., Chan A., Versteeg R., and Speleman F. Analysis of 1;17 translocation breakpoints in neuroblastoma: implications for mapping of neuroblastoma genes. Eur J Cancer 33 (1997) 1974-1978
12. Van Roy N., Laureys G., Cheng N.C., Willem P., Opdenakker G., Versteeg R., and Speleman F. 1;17 translocations and other chromosome 17 rearrangements in human primary neuroblastoma tumors and cell lines. Genes Chromosomes Cancer 10 (1994) 103-114
13. Stark B., Jeison M., Glaser-Gabay L., Bar-Am I., Mardoukh J., Ash S., Atias D., Stein J., Zaizov R., and Yaniv I. der(11)t(11;17): a distinct cytogenetic pathway of advanced stage neuroblastoma (NBL) - detected by spectral karyotyping (SKY). Cancer Lett 197 (2003) 75-79
14. Stallings R.L., Carty P., McArdle L., Mullarkey M., McDermott M., Breatnach F., and O'Meara A. Molecular cytogenetic analysis of recurrent unbalanced t(11;17) in neuroblastoma. Cancer Genet Cytogenet 154 (2004) 44-51
15. Avet-Loiseau H., Venuat A.M., Benard J., Leibovitch M.P., Hartmann O., and Bernheim A. Morphologic and molecular cytogenetics in neuroblastoma. Cancer 75 (1995) 1694-1699
16. Selzer R.R., Richmond T.A., Pofahl N.J., Green R.D., Eis P.S., Nair P., Brothman A.R., and Stallings R.L. Analysis of chromosome breakpoints in neuroblastoma at sub-kilobase resolution using fine-tiling oligonucleotide array CGH. Genes Chromosomes Cancer 44 (2005) 305-319
17. Stallings R.L., Nair P., Maris J.M., Catchpoole D., McDermott M., O'Meara A., and Breatnach F. High-resolution analysis of chromosomal breakpoints and genomic instability identifies PTPRD as a candidate tumor suppressor gene in neuroblastoma. Cancer Res 66 (2006) 3673-3680
18. Bourque G., Pevzner P.A., and Tesler G. Reconstructing the genomic architecture of ancestral mammals: lessons from human, mouse, and rat genomes. Genome Res 14 (2004) 507-516
19. Schleiermacher G., Janoueix-Lerosey I., Combaret V., Derre J., Couturier J., Aurias A., and Delattre O. Combined 24-color karyotyping and comparative genomic hybridization analysis indicates predominant rearrangements of early replicating chromosome regions in neuroblastoma. Cancer Genet Cytogenet 141 (2003) 32-42
20. Janoueix-Lerosey I., Hupe P., Maciorowski Z., La Rosa P., Schleiermacher G., Pierron G., Liva S., Barillot E., and Delattre O. Preferential occurrence of chromosome breakpoints within early replicating regions in neuroblastoma. Cell Cycle 4 (2005) 1842-1846
21. Woodfine K., Fiegler H., Beare D.M., Collins J.E., McCann O.T., Young B.D., Debernardi S., Mott R., Dunham I., and Carter N.P. Replication timing of the human genome. Hum Mol Genet 13 (2004) 191-202
22. Elliott B., Richardson C., and Jasin M. Chromosomal translocation mechanisms at intronic alu elements in mammalian cells. Mol Cell 17 (2005) 885-894
23. Kolomietz E., Meyn M.S., Pandita A., and Squire J.A. The role of Alu repeat clusters as mediators of recurrent chromosomal aberrations in tumors. Genes Chromosomes Cancer 35 (2002) 97-112
24. Murphy W.J., Larkin D.M., Everts-van der Wind A., Bourque G., Tesler G., Auvil L., Beever J.E., Chowdhary B.P., Galibert F., Gatzke L., Hitte C., Meyers S.N., Milan D., Ostrander E.A., Pape G., Parker H.G., Raudsepp T., Rogatcheva M.B., Schook L.B., Skow L.C., Welge M., Womack J.E., O'Brien S.J., Pevzner P.A., and Lewin H.A. Dynamics of mammalian chromosome evolution inferred from multispecies comparative maps. Science 309 (2005) 613-617
25. Roix J.J., McQueen P.G., Munson P.J., Parada L.A., and Misteli T. Spatial proximity of translocation-prone gene loci in human lymphomas. Nat Genet 34 (2003) 287-291